This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Secor, W. E.
Right arrow Articles by Freeman, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Secor, W. E.
Right arrow Articles by Freeman, G. L., Jr.

 Previous Article  |  Next Article 

Infection and Immunity, June 2001, p. 4177-4179, Vol. 69, No. 6
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.6.4177-4179.2001

Differential Vbeta T-Cell Receptor Usage during Chronic Experimental Schistosomiasis Corresponds with Distinct Pathological Presentations

W. Evan Secor* and George L. Freeman Jr.

Immunology Branch, Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Atlanta, Georgia 30341-3724

Received 16 January 2001/Returned for modification 6 March 2001/Accepted 16 March 2001

CBA/J male mice with chronic Schistosoma mansoni infections display either moderate splenomegaly syndrome (MSS) or hypersplenomegaly syndrome (HSS). As MSS and HSS mice differ in several immunologic characteristics, we investigated T-cell receptor Vbeta usage. The groups had significantly different expression of several Vbeta s, suggesting a relationship between the T-cell repertoire and schistosomiasis pathology.


* Corresponding author. Mailing address: Immunology Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention, 4770 Buford Hwy., NE, MS-F13, Atlanta, GA 30341-3724. Phone: (770) 488-4115. Fax: (770) 488-3115. E-mail: was4{at}cdc.gov.


Infection and Immunity, June 2001, p. 4177-4179, Vol. 69, No. 6
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.6.4177-4179.2001